Table 3 Patient sociodemographic and clinical characteristics
Characteristic | Patientsa |
|---|---|
Age, years, mean (SD) | 61.9 (13.1) |
Sex , n (%) | |
Male | 111 (55.8%) |
Female | 88 (44.2%) |
Marital status (n = 186), n (%) | |
Married/co-habitation | 135 (72.6%) |
Single | 20 (10.8%) |
Widowed | 18 (9.7%) |
Separated/divorced | 13 (7.0%) |
Educational leve [(n = 179), n (%)] | |
No formal education | 18 (10.1%) |
Primary education | 68 (38.0%) |
Secondary education | 52 (29.1%) |
University studies/postgraduate studies | 41 (22.9%) |
Time elapsed in years since diagnosis of GI-NET , mean (SD) | 2.87 (3.6) |
Time elapsed (years) since the 1 st intervention , mean (SD) | 2.73 (3.6) |
Time elapsed (months) between diagnosis and 1 st intervention , mean (SD) | 1.7 (5.9) |
Pharmacological treatment , n (%) | |
No current pharmacological treatment | 67 (33.7%) |
Somatostatin analogues | 113 (56.8%) |
Chemotherapy | 21 (10.6%) |
Interferon | 2 (1.0%) |
Targeted therapy | 21 (10.6%) |
Other | 5 (2.5%) |
Presence of symptoms , n (%) | |
No | 104 (52.3%) |
Yes | 95 (47.7%) |
Clinical status according to treating physicianb, n (%) | |
Stable | 151 (75.9%) |
Worsening | 20 (10.1%) |
Improving | 28 (14.1%) |
ECOG scores, n (%) | |
ECOG 0 | 100 (50.3%) |
ECOG 1 | 81 (40.7%) |
ECOG 2 | 16 (8.0%) |
ECOG 3 | 2 (1.0%) |
Presence of concomitant illness, n (%) | 75 (37.7%) |
No | |
Yes | 124 (62.3%) |
Clinical assessment of patient’s health, n (%) | |
Good | 169 (84.9%) |
Neither good nor poor | 9 (4.5%) |
Poor | 21 (10.6%) |